Cancer Research UK logo.
SearchDonate
  • Search

A trial looking at docetaxel, zoledronic acid and strontium 89 for prostate cancer that has spread to the bones (Trapeze trial)

Overview

Cancer types:

Prostate cancer

Status:

Results

Phase:

Phase 3

Details

This trial looked at finding the best combination of treatment to give to men when their cancer had spread to their bones.

Recruitment start: 1 February 2005

Recruitment end: 29 February 2012

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Professor Nick James

Supported by

Experimental Cancer Medicine Centre (ECMC)

GE Healthcare

NIHR Clinical Research Network: Cancer

NIHR Health Technology Assessment (HTA) programme

Novartis

Sanofi Aventis

University of Birmingham

Last reviewed: 13 February 2017

CRUK internal database number: 629

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and support

An icon of a hand shake.

Questions for your doctor

What to ask your doctor about clinical trials.

An icon of two speech bubbles, indicating a conversation.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.